Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To investigate the effectiveness and safety of BI 671800 given in the morning (AM), evening
(PM) or twice daily (b.i.d.) compared too placebo as add on therapy to inhaled corticosteroid
in symptomatic asthma patients.